Mineralocorticoid Receptor Antagonists in ESKD.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY(2020)
摘要
There is an urgent need for interventions that reduce cardiovascular risks in patients with ESKD. Recently there has been considerable interest in whether blocking the effects of the mineralocorticoid aldosterone could be such an intervention.
Since the 1980s, we have known that plasma aldosterone
更多查看译文
关键词
Humans,mineralocorticoid receptor antagonists,renal dialysis,aldosterone,mineralocorticoids,cardiovascular diseases,risk factors,chronic kidney failure,chronic renal insufficiency,hyperaldosteronism,heart failure,diabetes mellitus,hospitalization,Kidney Failure,Chronic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络